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Because of their somatic cell origin, human induced
pluripotent stem cells (HiPSCs) are assumed to carry
a normal diploid genome, and adaptive chromo-
somal aberrations have not been fully evaluated.
Here, we analyzed the chromosomal integrity of 66
HiPSC and 38 human embryonic stem cell (HESC)
samples from 18 different studies by global gene
expression meta-analysis. We report identification
of a substantial number of cell lines carrying full
and partial chromosomal aberrations, half of which
were validated at the DNA level. Several aberrations
resulted from culture adaptation, and others are
suspected to originate from the parent somatic cell.
Our classification revealed a third type of aneuploidy
already evident in early passage HiPSCs, suggesting
considerable selective pressure during the reprog-
ramming process. The analysis indicated high inci-
dence of chromosome 12 duplications, resulting in
significant enrichment for cell cycle-related genes.
Such aneuploidy may limit the differentiation
capacity and increase the tumorigenicity of HiPSCs.
INTRODUCTION
Numerous studies have thus far demonstrated that induction of
a small number of genes is sufficient to convert normal human
somatic cells into pluripotent stem cells (HiPSCs), which very
closely resemble human embryonic stem cells (HESCs) (Lowry
et al., 2008; Park et al., 2008; Takahashi et al., 2007; Yu et al.,
2007). This similarity has been demonstrated by gene expression
profiling and epigenetic signatures as well as by differentiation
potential. The expected impact of cellular reprogramming on
the future of medicine cannot be overestimated given that it
promises to provide an unlimited source of patient specific cells
for replacement therapy and for the study of genetic diseases.
However, the benefits of HiPSCs could be jeopardized by safetyCconcerns such as their tumorigenicity. Although much effort has
been recently made to reduce potential hazardous effects of the
reprogramming vectors, there is a need for a thorough analysis of
the reprogrammed cells’ propensity for chromosomal aberra-
tions. Thus far, no major aneuploidy has yet been demonstrated
to occur in HiPSCs. In comparison, although HESCswere initially
considered to have a stable normal genome copy number, it is
now widely accepted that during long-term culture of the cells
they stochastically acquire chromosomal aberrations that may
confer a growth advantage so that the aneuploid cells quickly
take over the population (Baker et al., 2007). Such progressive
adaptive copy number aberrations aremost commonly identified
in chromosomes 12, 17 and X (Baker et al., 2007; Draper et al.,
2004). So far, studies describing HiPSCs characterized them at
relatively early passage numbers and mainly reported normal
karyotypes (Lowry et al., 2008; Park et al., 2008; Takahashi
et al., 2007; Yu et al., 2007).
The genetic integrity of ESCs and iPSCs was previously
analyzed mostly by karyotype, but also at high resolution with
comparative genomic hybridization (CGH) or single-nucleotide
polymorphism (SNP) arrays. Such analyses directly measure
either DNA content or chromosome morphology. We now
suggest that the chromosomal integrity of HESCs and HiPSCs
can be examined by transcriptional profiling, to identify genomic
regions containing large clusters of genes with significantly
higher or lower levels of gene expression. This is possible by
comparison of each individual gene expression profile to a refer-
ence baseline made up of a very large number of highly similar
cell lines. In recent years the correlation between copy number
and levels of gene expression has been extensively recognized,
primarily in cancers, but also in natural human and rodent popu-
lations (Guryev et al., 2008; Henrichsen et al., 2009; Hughes
et al., 2000; Phillips et al., 2001; Pollack et al., 2002; Schoch
et al., 2005; Stranger et al., 2007; Tsafrir et al., 2006). It has
been further suggested that regionswith biased gene expression
are correlated with chromosomal abnormalities (Crawley and
Furge, 2002; Furge et al., 2005; Hertzberg et al., 2007; Lilljebjo¨rn
et al., 2007; Masayesva et al., 2004; Pollack et al., 2002; Tsafrir
et al., 2006). The ability to detect genomic aberrations with
data from gene expression arrays enables a comprehensive
study of genomic aberrations in multiple lines from variousell Stem Cell 7, 521–531, October 8, 2010 ª2010 Elsevier Inc. 521
Cell Stem Cell
Detection of Chromosomal Aberrations in HiPSCslaboratories. Such analysis cannot be currently performed by
direct DNA analysis, given that much of the biological material
is not available. Here, we applied two complementary tests to
identify regions of presumed aneuploidy in pluripotent stem cells
on the basis of their global gene expression profile.
RESULTS
Data Collection and Analysis
Gene expression data consisted of 104 unique gene expression
profiles from 18 studies; 38 samples of 17 unique HESC lines and
66 samples (clones and subclones) of 46 unique HiPSC lines
originating from 17 independent somatic cell lines (See Tables
S1 and S2 available online). Analysis was performed on
expressed genes with known chromosomal location only. Data
were further filtered to retain only a single instance of each auto-
somal gene, resulting in a total of 12,054 data points. For each
sample, the expression value of each gene was divided by the
median of the same gene across the entire dataset, in order to
obtain a comparative value. These values were then used in
two statistical tests in order to assess aneuploidy. In the first
test, overexpressed genes were determined for each sample
(>1.5 fold, relative to the median) and then subjected to location
enrichment analysis, using two gene expression analysis soft-
ware: Expander (Sharan et al., 2003) and EASE (Hosack et al.,
2003). In the second test, we applied the processed expression
data to comparative genomic hybridization (CGH) analysis soft-
ware, CGH-Explorer (Lingjaerde et al., 2005). Using the
program’s piecewise constant fit (PCF) algorithm, we were
able to analyze gene expression regional bias in all our samples
by using a constant set of parameters. The results of the PCF can
often be clearly seen in a moving average plot of the gene
expression profile. It is important to note that although both
methods rely on the same expression data, they are comple-
mentary. The first method counts genes that are clearly overex-
pressed and tests for chromosomal enrichment, whereas the
second method analyzes the spatial expression pattern of all
expressed genes.
Identification and Validation of Aneuploidy in HESCs
with Expression Data
To explore the potential of this system to identify aneuploidy, we
first analyzed two HESC lines predetermined by preimplantation
genetic screening (PGS) to harbor a single trisomic chromosome
each, either 17 or 21. These trisomies were verified by high-
density SNP-array copy number analysis (Figure 1A). Gene
expression profiling was performed for these cell lines in parallel
with the genomic analysis. The trisomic chromosomes (17 and
21) were found to have highly significant over-representation of
overexpressed genes (Bonferroni corrected p values = 13 107
by Expander and 2.13 109 by EASE, for chromosome 17; 4.93
104 by Expander and 1.1 3 1010 by EASE, for chromo-
some 21), (Figure 1B and Figure S1A). These results were verified
by the PCF algorithm and are also clearly visible with a moving
average plot relative to similarly derived normal diploid cells
(Figure 1C).
Most aneuploidies in HESCs were identified in culture-adap-
ted cells (Baker et al., 2007; Draper et al., 2004). Such cytogenet-
ically verified chromosomes and chromosome arms were522 Cell Stem Cell 7, 521–531, October 8, 2010 ª2010 Elsevier Inc.correctly identified by enrichment analysis of the overexpressed
genes (Figures 1D and 1E and Figures S1B–S1D). The entire set
of identified trisomies analyzed by the expression profile of
HESCs is shown in Table S1. Next, we explored the possibility
of using PCF to detect subchromosomal gains or losses in the
HESC data set. This method could detect both cytogenetically
verified multiple copy amplification (Figure 1F) and single-copy
duplication (Figure 1G). Analysis of the entire HESC data set
revealed chromosomal aberrations in 12 out of the 38 cell lines.
Eight of these aberrations involved entire chromosomes or large
chromosomal regions that were thus apparent by both expres-
sion analyses, three of which could be confirmed by karyotype
(Table S1). Not all the aberrations identified by gene expression
could be analyzed cytogenetically because of lack of corre-
sponding cells or DNA from similar passage. Notably, the most
recurrent duplications were in chromosomes 12 and 17 (three
cell lines each), coinciding with their previously suggested role
in embryonic tumors and ESC adaptation (Baker et al., 2007;
Reuter, 2005) (Table S1, Figures 1D–1F, and Figures S1B–S1D).
Aneuploidy Detection in HiPSCs with Expression Data
HiPSCs are similar to HESCs in many respects, even though
some differences have been observed between the two cell
types (Chin et al., 2009). Although it might be presumed that
HiPSCs would acquire genetic abnormalities in a similar manner
to HESCs, the unique nature of their derivation may make them
different in this regard. We thus aimed to analyze the genetic
instability of HiPSCs. Of the 66 HiPSC samples included in this
study, two lines were previously reported to harbor two trisomic
chromosomes each (chromosomes 1 and 9). Using the same
methods and parameters as for HESCs, we correctly identified
these aberrations (Figures 2A and 2B). Two other HiPSC studies
reported subchromosomal genomic aberrations. In the study of
Yu et al. (2009), 16 HiPSC clones and subclones were deter-
mined to be normal by karyotype and a single small deletion in
one subclone was identified by high-density CGH arrays
(Yu et al., 2009). Here, by examining the corresponding gene
expression data, we identified the same small deletion in chro-
mosome 15 as the sole aneuploidy in the entire set of samples
from this study (Figure 2C). In another study (Chin et al., 2009),
CGH-array analysis revealed a number of possible aberrations
at varying confidence levels, the three most significant of which
were correctly reproduced by our gene expression analysis
(Figures S2A–S2C). However, the events that were suggested
by CGH at low confidence were not detected by this analysis.
This could suggest that gene expression-based analysis might
not be adequate to detect changes in a minority of cells within
a mixed population.
In addition to the verification of previously reported genetic
abnormalities, we could identify many chromosomal aberrations
that were established early on during the isolation of HiPSCs, or
during their prolonged culture. As seen in Figure 2D, the HiPSC
line, HiPSC1-8 (Masaki et al., 2007), contains an abnormally
high frequency of overexpressed genes in chromosome 12,
which is present already at passage 14, and the level of overex-
pressed genes is even higher at passage 31. The evidence of
trisomy 12 is also very clear in the respective moving average
plots, in which the aneuploidy is evident at low passage and
takes over the culture at the higher passage (Figure 2E). Another
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Figure 1. Identification of Chromosomal
Aberrations in HESCs with Gene Expression
Analysis
(A–C) Identification of aneuploidy in preimplanta-
tion genetic screening (PGS) derived HESC lines:
(A) High density SNP-array copy number analysis
of: CSES7 (46XX); CSES8 (47XX+17); and
CSES21 (47XY+21).
(B) Whole chromosome gain analysis of overex-
pressed genes. Bars represent fold enrichment
of overexpressed genes in each particular chro-
mosome relative to the expected random
frequency. CSES8 shows significant enrichment
of overexpressed genes in chromosome 17 (Bon-
ferroni corrected p value = 1*107 by Expander
and 2.1 3 109 by EASE), CSES21 shows signifi-
cant enrichment in chromosome 21 (Bonferroni
corrected p value = 4.9 3 104 by Expander and
1.1*1010 by EASE).
(C) Gene expression profile moving average plot
demonstrates homogenous overexpression of
genes along the abnormal chromosomes.
(D–G) Identification of aneuploidy in culture adap-
ted HESCs.
(D) Identification of trisomies 12 and 17 in the H14-
HSR+ cell line (Baker et al., 2007) by whole-chro-
mosome analysis (Bonferroni corrected p value =
5.5 3 1018 by Expander and 3.6 3 1018 by
EASE, for chromosome 12; 2.6 3 1018 by
Expander and 1.5 3 1012 by EASE, for chromo-
some 17), but not in the normal parental H14 cell
line (Table S2).
(E) The same trisomies shown by moving average
plot.
(F) Tandem multiple copy number gain in proximal
17p in the adapted cell line H14-HSR+.
(G) Single copy number gain in distal 1p in the
chHES-3 cell line (Yang et al., 2008). Two samples
of different passages carrying the same aberration
46XX,dup(1)(p32p36) relative to a normal cell line
from the same study are shown.
Asterisks indicate p value < 1 3 104, judged by
Expander and EASE location analyses. All signifi-
cance tests are presented after Bonferroni multiple
test correction. Vertical dashed lines represent
cytogenetic boundaries of chromosomal aberra-
tions as described in the respective studies. Hori-
zontal colored bars represent piecewise constant
fit (PCF) abnormality detection as described in
the methods section.
For further examples of detection of aneuploidy in
HESCs, see also Figure S1. For a detailed list of
HESC lines, see Table S1.
Cell Stem Cell
Detection of Chromosomal Aberrations in HiPSCscell line, hiPSC18 (Chin et al., 2009; Lowry et al., 2008), was
found normal by gene expression analysis at passage 9,
whereas by passage 56 both PCF and Expander/EASE analyses
predicted gains in chromosomes 3 and 12 (Figures S2D
and S2E).
Because chromosomal duplications can occur in some cell
lines after a relative small number of passages, as described
above, we speculated it might be possible to enhance or
generate them de novo by growing these cells in culture. There-
fore, we decided to re-examine the hiPSC18 line (Chin et al.,C2009; Lowry et al., 2008), which seemed susceptible to chromo-
somal aberrations. This cell line had a normal karyotype at
passage 45 (20/20 metaphases, Figure 3A) and was further
grown until passage 63, when it was analyzed in parallel by
karyotype and gene expression. Interestingly, these cells
acquired a full trisomy of chromosome 12, as demonstrated by
karyotype analysis (Figure 3C). Moreover, both the Expander/
EASE and the PCF analyses correctly identified the trisomywhile
not identifying any false duplication or deletion (Figures 3D–3F).
We can thus suggest that this trisomymay confer a major growthell Stem Cell 7, 521–531, October 8, 2010 ª2010 Elsevier Inc. 523
Figure 2. Identification of Chromosomal Aberrations in HiPSCs
(A) Detection of chromosome 1 and chromosome 9 trisomies in p-hiPS01 (Bonferroni corrected p values = 5.03 1032 by Expander and 1.13 1030 by EASE, for
chromosome 1; 6.03 1013 by Expander and 3.23 1018 by EASE, for chromosome 9) and p-hiPS02 (Bonferroni corrected p values = 4.03 1033 by Expander
and 4.53 1044 by EASE, for chromosome 1; 2.73 1012 by Expander and 2.23 1016 by EASE, for chromosome 9), as well as detection of chromosome 1 and
chromosome 9p trisomies in rv-hiPS01 (Bonferroni corrected p values = 1.3 3 1030 by Expander and 5.0 3 1046 by EASE, for chromosome 1; 1.4 3 107 by
Expander and 8.73 1013 by EASE, for chromosomal arm 9p). The original study described trisomy in chromosomes 1 and 9 in p-hiPS01 and p-hiPS02 as well as
in the parental somatic cell line (Kim et al., 2009).
(B) Moving average plot of the gene expression profile of these cell lines; iPS-DF6_9 is displayed as reference.
(C–E) Identification of aneuploidy acquired in culture.
(C) Identification of a small deletion described by Yu et al. (2009) in the subclone iPS-DF6_9_12T. All the other clones described in this study were found in our
analysis to be normal, congruent with the original report. The parental HiPSC line iPSC-DF6_9 and another subclone isolated from this line (iPS-DF6_9_9T) are
presented as normal reference.
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Detection of Chromosomal Aberrations in HiPSCsadvantage, as is evident from the rapid rate in which it is
acquired, coinciding with the high frequency at which this partic-
ular aberration has been found in our study (Figure 4A). In order
to learn more about the selection for the aneuploid cells, we per-
formed karyotype analysis at passage 58 of the same line (five
passages prior to the full trisomy detection). At this passage,
the culture was found to be mosaic, comprising both normal
and trisomic cells (47,XY,+12[9]/46,XY[11], Figure 3B). These
results suggest a rapid selection for cells with trisomy 12, as
was previously shown in HESCs for trisomy 17 (Olariu et al.,
2010).
All together, of the 66 HiPSC samples analyzed, we identified
thirteen (20%) abnormal lines, of which six (9%) carried at
least one full trisomy (Table S2). Cytogenetic information from
similar passage was available for nine of the aberrations and
all agreed with these findings (Table S2). Thus, we found many
more aberrations than were reported in the original studies.
This may be due to the higher resolution of the present analysis,
but in some cases can also be attributed to the fact that in many
cases gene expression and cytogenetic analyses presented by
the original studies were conducted at different passages. The
complete list of genomic aberrations identified in HiPSCs is
presented as Table S2. A schematic representation of the PCF
results is presented in Figure 4A, and gene level PCF calls are
presented in Tables S3A and S3B.
Adaptation of HiPSCs Is Associated with Elevated
Expression of Pluripotent and Cell Cycle-Related Genes
Investigation of the frequency of copy number gains in HiPSCs
demonstrates that chromosome 12 (and specifically 12p) is
the most recurrent (Figure 4A). This abnormality has been
described as a hallmark of testicular germ cell tumors (Reuter,
2005). The most recurrent autosomal gains in abnormal culture
adapted HESCs are of chromosomes 12 and 17 (Baker et al.,
2007). Interestingly, here we did not find a single instance of
gain in chromosome 17 in HiPSCs, whereas three were found
in the smaller HESC data set (Figure 4A). In all five HiPSC lines
that acquired a gain in the 12p region as a result of prolonged
time in culture, the hallmark pluripotency genes NANOG and
GDF3 are included in the duplication (Figure 4B). Moreover,
NANOG and GDF3 are significantly overexpressed in these
cell lines relative to all other HiPSC lines (p values = 4.3 3
105 and 2.9 3 1010, respectively; average fold change 31.6
and 34.4, respectively) (Figures 4C–4E). The higher levels of
these genes seem to be directly correlated with copy number
gain because other pluripotency genes, such as OCT4
(p value = 0.38) and SOX2 (p value = 0.95), are not differentially
expressed. The increase in expression of NANOG and GDF3
upon the selection for cells with trisomy 12 was confirmed in
the hiPSC18 line by quantitative RT-PCR. In this line, a significant
gradual increase in the expression of these genes was(D and E) Acquired chromosome 12 trisomy in two separately grown samples of
(D) The parental somatic cell andHiPSC 1-8 fromdifferent passages (14 and 31), s
by Expander and 1.0*1018 by EASE, for passage 14; 5.0*1036 and 1.3*1026, f
(E) Moving average plot of the gene expression profile of clone 1-8 at passages
a trisomy of chromosome 12, which was acquired very early in culture and grad
Asterisks indicate p value < 1*104, judged by Expander and EASE location ana
For further examples of detection of aneuploidy in HiPSCs, see also Figure S2. F
Cmeasured between the normal culture, the mosaic culture, and
the fully trisomic culture (Figure 4D).
Functional analysis of the expressed genes in recurring aber-
rant chromosomal regions in HiPSCs was performed with the
DAVID Functional Annotation tool (Dennis et al., 2003; Huang
et al., 2009). Expressed genes in chromosomal regions gained
in at least two independent HiPSC lines were significantly
enriched for cell cycle annotations (p value = 2.8 3 105)
(Table S3C). Such enrichment was not found in randomly chosen
chromosomal regions of the same size.
In order to further investigate the functional implications of
the recurring aberrant chromosomal regions, we examined
the effect of gains in chromosome 12 on the gene expression
profile of the entire genome. A total of 135 genes residing
outside chromosome 12 were found to be significantly differen-
tially expressed in the aberrant HiPSC lines that carry gains
in chromosome 12, relative to all the other HiPSC lines
(p value < 0.01). However, these genes were not significantly en-
riched for any functional annotation. In order to determine
whether the trisomic lines more closely resemble one another
in terms of overall gene expression, we performed unsupervised
hierarchical clustering of the entire data set of HESC and HiPSC
lines (HG-U133plus2 platform). Although it is evident that the
aberrant lines show consistently high gene expression levels
on the aberrant chromosomes, they do not cluster together.
The main contribution to the way the samples cluster together
seems to be the laboratory and study of origin (Figure S3).
Sensitivity and Specificity of Statistical Tests
In order to determine the success rate of our analysis, we
analyzed the gene expression profiles of control and trisomic
HESC lines isolated from aneuploid PGS embryos. These lines
were cytogenetically analyzed by high-density SNP arrays and
karyotype at the same passage of RNA extraction. In the three
lines shown in Figure 1, we did not find a single false positive
event in which a diploid chromosome was identified as trisomic.
Because we do not expect trisomies that are established within
the cell culture to disappear, all known trisomies from the study
(both in HESCs and in HiPSCs) were used for assessing the false
negative rate. All such duplication events (of whole chromo-
somes or chromosome arms) were identified by both
Expander/EASE and PCF analyses of the expression profile
(11/11). Because of the tendency of cultured cells to acquire
de novo genetic alterations, for verification purposes it is imper-
ative to analyze gene expression data alongside cytogenetic
data obtained from very similar passages. Thus, in order to
further validate our methods, we used the lines from Yu et al.
(2009). In this study, 16 low passage HiPSC clones and sub-
clones were subjected to both array CGH and gene expression
analyses at very close passages. Out of these 16 HiPSC
samples, our analysis detected only one small deletion in a singleHiPSC 1-8 from Masaki et al. (2007).
howing trisomy in chromosome 12 (Bonferroni corrected p-values = 6.03 1010
or passage 31).
14 and 31, clone 3-2 is presented as normal reference. These results suggest
ually took over.
lyses after Bonferroni multiple test correction.
or a detailed list of HiPSC lines, see Table S2.
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Figure 3. Generation of Trisomy 12 in HiPSCs upon their Growth in Culture
(A) Karyotype analysis of hiPSC18 at passage 45. This cell line was also found normal by Array CGH-analysis at passage 48 (Chin et al., 2009).
(B) hiPSC18 at passage 58 acquired a full trisomy of chromosome 12 in approximately half the population (9/20 metaphases). Normal and trisomic karyotypes
from the same analysis are presented.
(C) By passage 63 of hiPSC18 trisomy 12 cells had taken over the culture.
(D) Whole chromosome gain analysis of hiPSC18 showing this cell line was normal at passage 9.
(E) Full trisomy of chromosome 12 was detected at passage 63 (Bonferroni corrected p value = 4.3 3 1047 by Expander and 1.6 3 1038 by EASE).
(F) Moving average plot of the gene expression profile of hiPSC18 at passages 9 and 63.
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Detection of Chromosomal Aberrations in HiPSCssubclone, whereas all the other lines were found to be
completely normal (Figure 2C). These results are identical to
the reported results from the CGH arrays, thus supporting both
the sensitivity and the specificity of our methods. Finally, we per-
formed parallel gene expression and SNP-array analyses of four
HiPSC lines generated by us. All four lines were determined to be
normal diploid lines in both the SNP-array and the Expander/526 Cell Stem Cell 7, 521–531, October 8, 2010 ª2010 Elsevier Inc.EASE and PCF tests, further confirming the specificity and low
false positive rate of these tests.
In total, the combination of Expander/EASE and PCF analyses
identified 19 aberrations in the test data. Nine of these aberra-
tions were also confirmed by direct chromosomal or DNA-based
analysis, whereas nonewas refuted by such analyses. In order to
assess the false positive rate of the Expander/EASE analysis
Figure 4. Functional Analysis of Recurring Chromosomal Aberrations in HiPSCs
(A) Ideogramrepresentinggainedchromosomal regions identifiedbyPCFanalysis.Redbars representagainof the respectivechromosomal region inone line.Darkand
light bars represent gains inHiPSCs andHESCs, respectively. Similar chromosomal aberrations in different passages of the same cell line are interconnected by a line.
(B) Representation of chromosome 12 gains identified by PCF analysis. Each bar represents a gain of the respective chromosomal region.
(C) Comparison ofNANOG andGDF3 expression between the five aberrant HiPSCs and HiPSCs lines with normal chromosome 12 copy number, showing that both
genes are significantly overexpressed in the lineswith gains in chromosome 12 (p values = 4.33 105 and 2.93 1010; average fold changes31.6 and34.4, respec-
tively; error bars represent SEM).
(D) qRT-PCR expression of NANOG and GDF3 at three different passages of hiPSC18, demonstrating their expression increase upon selection for trisomy 12 in the
culture (normalized to b-Actin). Asterisks indicate p value < 0.05.
(E) Volcanoplot showingoverexpressionandunderexpressionof genes residing in theminimalgained regioncommontoall five aberrantHiPSCs, in theseaberrant lines
relative to lines with normal chromosome 12 copy number.
(F) Schematicmodel of the different types of chromosomal aberrations found inHiPSCs: aberrationswith somatic cell origin (‘‘A’’); aberrations present in early passage
but without apparent somatic cell origin (‘‘B’’); and aberrations acquired during prolonged culture (‘‘C’’).
Cell Stem Cell
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Detection of Chromosomal Aberrations in HiPSCs(i.e., the false positive rate of full trisomies based on gene
expression profiles), we examined all lines that underwent direct
chromosomal or DNA-analysis and gene expression profiling at
similar passages. None of the 613 normal chromosomes was
falsely detected as trisomic (false positive rate between 0 and
0.006, with 95%confidence). In order to assess the false positive
rate of the PCF method for the detection of subchromosomal
aberrations, we generated randomized data for each cell line
using its own gene expression data. This was performed five
times and a total of only two false positive aberrations were
found (at an average size of 90 probes). In the analysis of
HESC and HiPSC lines, we identified a total of 45 discreet aber-
rations. Thus, the estimated false positive rate is 0.0038
(between 0.0005 and 0.0138, with 95% confidence). The small-
est reported aberrations in the published data we examined
were gain of 11.7 Mb and losses of 8.8 Mb and 11.2 Mb (corre-
sponding to 86, 44, and 85 expressed genes, respectively).
These were all correctly identified by our analysis, indicating
that the current validated resolution of the analysis is 10 Mb.
Because regional epigenetic modifications and coregulation
might lead to misinterpretation of the gene expression data,
we set out to further validate that our findings indeed represent
chromosomal aberrations and not epigenetic effects. We con-
ducted functional GO analysis on the regions found by PCF to
be aberrant in one or more HiPSC lines and could not detect
enrichment for any functional annotation that might suggest cor-
egulation. Moreover, we could not detect aberration calls in
regions of genes that are known to be clustered together and
coregulated, such as the imprinting locus in chromosome 15.
However, epigenetic effects are very significant in the case of
the X chromosome, precluding its analysis by this methodology.
Upon analysis of chromosome X, some of the female lines were
found to have the same level of gene expression as the male
lines, whereas other female lines showed regional overexpres-
sion in chromosome X (Figure S2F). These results may suggest
that X chromosome inactivation is variable in the female cell
lines.DISCUSSION
In this study, we examined the chromosomal stability of multiple
HiPSC lines through the analysis of gene expression data.
Previous studies comparing gene expression with copy number
alterations indicated a strong correlation between copy number
and gene expression. Here, we identified aneuploidy through the
detection of regions of biased gene expression in multiple HESC
and HiPSC lines.
The validity of our methodology was established in a prospec-
tive study in which SNP and gene expression analyses of HESCs
and HiPSCs were conducted simultaneously. The methodology
was further confirmed in a retrospective analysis of chromo-
somal aberrations which were previously reported in pluripotent
stem cells. Thus, we identified 19 aberrations by both PCF and
Expander/Ease analyses. In all cases in which direct DNA
content analysis was available from similar passage as the
gene expression, they were in agreement (nine aberrations).
The high confidence of our results can be attributed to a large
degree to the quality of the data set, which consisted of a large528 Cell Stem Cell 7, 521–531, October 8, 2010 ª2010 Elsevier Inc.set of lines that demonstrate homogenous gene expression
profiles.
Expression-based analysis has several important advantages:
First, the functionality of the genomic abnormalities thus identi-
fied becomes immediately apparent with the identification of
the genes whose expression is actually aberrant; second, the
same biological material is used both for gene profiling and for
assessment of the chromosomal integrity; third, it allows
conducting retrospective examinations of genetic integrity; and
lastly, the method allows detection of chromosomal duplications
and deletions at higher resolution than standard karyotype
analysis.
However, this methodology also has several limitations: First,
only cell lines whose gene expression profile has been analyzed
with the same platform can be compared to each other; second,
because of the higher noise of gene expression data, this
method is not as sensitive as CGH arrays, SNP arrays, or karyo-
type analysis in identifying abnormalities that exist only in
a subpopulation in the culture. Furthermore, resolution is limited
by the number of expressed genes in the sample. The unbal-
anced distribution of genes along the genome also dictates
that euchromatic regions with higher gene abundance will be de-
tected at higher resolution than heterochromatic regions; lastly,
epigenetic regional modifications may also affect the interpreta-
tion of the data (Stransky et al., 2006).
Despite these limitations, we could successfully use gene
expression profiling to detect chromosomal aberrations in plurip-
otent cells, by combining two statistical methods. These were
consistently verified by direct DNA content analysis, on both
HESCs and HiPSC lines, where such material was available.
Prior to this study, no comprehensive evaluation of the
genomic integrity of HiPSCs has been reported. Most of the
karyotypes of HiPSCs were conducted and reported during their
initial characterization as pluripotent cells. Here, we identified
thirteen (20%) abnormal lines, of which six (9%) carried at
least one full trisomy (Figure S2). Because of the nature of
gene expression profiling, abnormalities can only be identified
if present in the majority of the cell population. Thus, any abnor-
mality found should either have been present in the parental
somatic cell line or to have been selected for. We could therefore
divide the genomic aberrations identified in HiPSCs by this
method to three general categories: A, aberrations with somatic
cell origin; B, aberrations present in early passage but without
apparent somatic cell origin; and C, aberrations acquired during
passaging of the cells (Figure 4F).
In the first group are the HiPSC lines from the study by Kim
et al. (2009). In their study, they report the derivation of three
HiPSC lines by either direct reprogramming using proteins or
by retroviral induction. The karyotypes for both the direct reprog-
rammed lines and the somatic cells (human newborn fibroblasts)
were shown to be abnormal with trisomies in both chromosomes
1 and 9 (Kim et al., 2009). Here, we identify both trisomic chromo-
somes in the direct delivery lines as well as in the retroviral
induced line, for which karyotype analysis was not provided in
the original study (Figures 2A and 2B). Surprisingly, we could
not detect corresponding aneuploidy in the somatic cell. This
would indicate possible mosaicism in the parental somatic cells
and a selective advantage conferred to the fibroblasts that
carried these trisomies. Interestingly, chromosome 9 is known
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McIntyre et al., 2007; Reuter, 2005).
The second group of aberrations consists of a number of early
passage HiPSCs (passages 5 to 16) harboring sub-chromo-
somal duplications or deletions (Table S2). In contrast to the
previous group, these aberrations seem to originate from events
of genetic instability during the isolation and culture of the HiPSC
lines, given that additional clones from the same source do not
share the same aberrations. Moreover, no corresponding aber-
rations were found in the parent somatic cells. Thus, it seems
that a rapid selection for certain aneuploidies occurs during the
reprogramming process and the establishment of HiPSCs. This
category of genomic instability, seen in HiPSCs but not in
HESCs, adds to the accumulating data regarding the differences
between these types of pluripotent cells.
The third group contains HiPSC lines that acquired chromo-
somal abnormalities upon prolonged time in culture (Figures
2D and 2E and Figures S2D and S2E). Of the four independent
lines for which there is data from multiple passages, three
acquired major aberrations. Notably, all these lines acquired
copy number gains of either entire chromosome 12 or part of
the short arm 12p.
The aberrations identified are non-randomly distributed, with
the highest incidence occurring in chromosome 12, which has
been previously shown to be involved in HESC adaptation.
Importantly, gains in the 12p region were found in all five adapted
high passage HiPSC lines, and full trisomy of chromosome
12 could be produced de novo upon culturing. Interestingly, in
this study we did not detect aberrations of chromosome 17 in
any of the HiPSC lines, whereas three such trisomies were de-
tected in the smaller data set of HESC lines.
Using the gene expression data, we further demonstrated that
these nonrandom aberrations indeed have functional implica-
tions. The hallmark pluripotency genes NANOG and GDF3
were significantly overexpressed in the lines that possessed
a gain in 12p. Moreover, functional annotation analysis revealed
a considerable enrichment for cell cycle genes among the aber-
rant HiPSC lines. This is congruent with recent findings that cell
division rate is a crucial parameter in the success and efficiency
of the reprogramming process (Hanna et al., 2009). Interestingly,
the same upregulation of NANOG, GDF3, and cell cycle genes
were observed in the de novo generated trisomy 12 HiPSC
line. The rapid rate at which this trisomy appeared demonstrates
the functional significance of these gene expression abnormali-
ties in conferring selective growth advantage to the cells that
carry them, consistent with previous findings from chromosomal
aberrations in HESCs (Olariu et al., 2010).
The relatively high incidence of aneuploidy in HiPSCs could be
a side effect of the reprogramming process, in which integrating
viral vectors are often used. Viral integrations have been previ-
ously shown to cause chromosomal aberrations in a proximity
to the site of integration (Kadaja et al., 2009). In this study we
did not observe higher incidence of aneuploidy in viral-derived
HiPSC lines relative to lines derived without viral integration.
Out of 14 confirmed aberrations in HiPSCs, five were evident in
lines that were derived without viruses. Concurrently, of the
48 lines of HiPSCs derived by viral integrations, most were found
to be normal. Moreover, many of the aneuploidies identifiedwere
of whole chromosomes or of very large chromosomal regionsCthat are unlikely to have arisen because of viral integration-medi-
ated process.
In conclusion, evaluation of the extent and nature of HiPSC
genomic instability is important for both basic research and
future clinical use. As was previously suggested and demon-
strated regarding HESCs, such chromosomal aberrations might
affect the differentiation capacity of the cells and increase their
tumorigenicity (Blum and Benvenisty, 2009; Draper et al., 2004;
Enver et al., 2005). More immediate implications apply for basic
research, given that these chromosomal aberrations are likely to
influence the interpretation of biological studies of HiPSCs. Thus,
careful analysis of the genetic integrity of HiPSCs during culture
is required, even at early passages.
EXPERIMENTAL PROCEDURES
Cell Culture
HESCs and HiPSCs were cultured on mitomycin C-treated mouse embryonic
fibroblast (MEF) feeder layer and passaged as detailed in Supplemental Exper-
imental Procedures.
Copy Number Variation Analysis
DNA was isolated from the HESC and HiPSC lines and analyzed by Genechip
Human Mapping 250K Sty Array or by Human Mapping 500K Array in accor-
dance with the manufacturer’s protocol (Affymetrix, CA). Copy-number varia-
tion results were analyzed using the Partek Genomics Suite version 6.3
(Partek, MO; http://www.partek.com) with the 270 samples of the Human
HapMap Project used as baseline. Data from the 250K arrays were analyzed
with the Hidden Markov Model default settings in the copy number workflow
in Partek Genomics Suite. The working definition of trisomy is a chromosome
with multiple contiguous loci in which the relative copy number is three instead
of two.
Gene Expression Profiles Database
Gene expression profiles from 18 studies that involved HESCs and/or HiPSCs
and that conducted DNAmicroarray analysis with HG-U133plus2 or HG-ST1.0
microarray platforms (Affymetrix), were obtained from the GEO (Gene Expres-
sion Omnibus; http://www.ncbi.nlm.nih.gov/geo) and EMBL-EBI (http://www.
ebi.ac.uk) databases. Raw .CEL files for all samples were analyzed with MAS5
or RMA probe set condensation algorithm with Expression Console
(Affymetrix). Arrays were analyzed for quality control and outliers were
removed. Further outliers were removed following hierarchical clustering anal-
ysis. Probes were filtered to retain a single instance for each gene expressed
by >80% of the samples (see Supplemental Experimental Procedures), result-
ing in 12,054 data points. Values under 50 (for HG-U133plus2) or 6.0 (for HG-
ST1.0) were collectively raised to this level. For reduction of possible bias from
any given experiment, groups of similar samples with highly similar gene
expression profiles (as judged by hierarchical clustering) were averaged for
the sake of calculating the grand population median. This median then served
as the baseline for examining expression bias.
Location Enrichment Analysis
For each chromosome for each cell line, the percentage of genes overex-
pressed >1.5-fold relative to the median expression of that gene was calcu-
lated. Enrichment of whole chromosomes or chromosomal arms was deter-
mined by subjecting the list of overexpressed genes of each line to location
enrichment analysis with the software Expander (http://acgt.cs.tau.ac.il/
expander) and EASE (http://david.abcc.ncifcrf.gov/ease/ease1.htm). Signifi-
cance was defined as Bonferroni corrected p values < 1.0 3 104, the default
value of the Expander program.
False positive and negative rates were calculated using exact binomial
confidence intervals (http://statpages.org/confint.html).
CGH-PCF Overexpression Analysis
For each sample, the expression value of each gene was divided by the
median of the same gene across the entire data set, in order to obtainell Stem Cell 7, 521–531, October 8, 2010 ª2010 Elsevier Inc. 529
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analysis program, CGH-Explorer (http://www.ifi.uio.no/forskning/grupper/
bioinf/Papers/CGH). Gene expression regional bias was detected with the
program’s piecewise constant fit (PCF) algorithm, with a constant set of
parameters (detailed in Supplemental Experimental Procedures).
Gene Ontology Analysis
For detection of significantly over-represented GO biological processes, the
DAVID functional annotation clustering tool (http://david.abcc.ncifcrf.gov)
was used (GO_TERM_BP_5). Expressed genes in chromosomal regions with
copy number gain according to PCF analysis in at least two independent
HiPSC lines were analyzed. General annotation categories with over 2000
members were excluded from the analysis. Enrichment was determined at
DAVID calculated Benjamini value <0.05. Significance of overexpression of
individual genes was determined with a standard Student’s t test.
Comparison of Gene Expression between Normal and Aberrant
Lines
Differentially expressed genes between the HiPSC lines with aberrations in
chromosome 12 and the rest of the lines was determined with the t test probe
filter function of Expander, with a 0.01 p value threshold and FDRmultiple tests
correction. NANOG and GDF3 expression values were compared using
Student’s t test. Hierarchical clustering was performed with Partek Genomics
Suite version 6.3 (Partek, MO; http://www.partek.com).
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Original microarray data are accessible at the GEO database under accession
numbers GSE21243 and GSE21244. References to all microarray data used in
this study are found in Tables S1 and S2.
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